vpera

Victor Pera, PharmD

PhD Student

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Social:linkedin logo

ORCID: 0000-0002-0786-4712

 

 

 

 

 

 

Background

Victor Pera obtained his BSc (2014) and MSc (2020) in Pharmacy from the University of Groningen (The Netherlands). In addition, he obtained a MSc (2020) in Medical Pharmaceutical Sciences with a specialization in the field of pharmaco-epidemiology at the University of Groningen (The Netherlands). He wrote his master thesis on the effectiveness of antibiotics for the treatment of COPD exacerbations by utilizing both the LifeLines and the IADB.nl database. In November 2020, Victor joined as a PhD candidate the Health Data Science group of the Medical Informatics department at the Erasmus University Medical Center (Rotterdam, The Netherlands) to conduct research on Medication Errors. He is working extensively with the FDA Adverse Event Reporting System (FAERS), the European Medicines Agency’s EudraVigilance, the Integrated Primary Case Information (IPCI) database, and utilizes tools from the Observational Health Data Sciences and Informatics (OHDSI) collaborative and the Data Analysis and Real World Interrogation Network (DARWIN EU®) to work on databases mapped to the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM).

Publications

Pera V, van Vaerenbergh F, Kors JA, et al. Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration’s Adverse Event Reporting System. Pharmacoepidemiology and Drug Safety. n/a(n/a). doi:10.1002/pds.5743
 
Pera V, Brusselle GG, Riemann S, Kors JA, Van Mulligen EM, Parry R, de Wilde M, Rijnbeek PR and Verhamme KMC (2023), Parasitic infections related to anti-type 2 immunity monoclonal antibodies: a disproportionality analysis in the food and drug administration’s adverse event reporting system (FAERS). Front. Pharmacol. 14:1276340. doi: 10.3389/fphar.2023.1276340
 
Ostropolets A, Albogami Y, Conover M, Banda JM, Baumgartner WA, Blacketer C, Desai P, DuVall SL, Fortin S, Gilbert JP, Golozar A, Ide J, Kanter AS, Kern DM, Kim C, Lai LYH, Li C, Liu F, Lynch KE, Minty E, Neves MI, Ng DQ, Obene T, Pera V, Pratt N, Rao G, Rappoport N, Reinecke I, Saroufim P, Shoaibi A, Simon K, Suchard MA, Swerdel JN, Voss EA, Weaver J, Zhang L, Hripcsak G, Ryan PB. Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational study. J Am Med Inform Assoc. 2023 Feb 24:ocad009. doi: 10.1093/jamia/ocad009. Epub ahead of print. PMID: 36826399.
 
Seinen TM, Fridgeirsson EA, Ioannou S, Jeannetot D, John LH, Kors JA, Markus AF, Pera V, Rekkas A, Williams RD, Yang C, van Mulligen EM, Rijnbeek PR. Use of unstructured text in prognostic clinical prediction models: a systematic review. J Am Med Inform Assoc. 2022 Jun 14;29(7):1292-1302. doi: 10.1093/jamia/ocac058. PMID: 35475536; PMCID: PMC9196702.
 
Wang Y, Pera V, Boezen HM, et al. Real-World Effects of Antibiotic Treatment on Acute COPD Exacerbations in Outpatients: A Cohort Study under the PharmLines Initiative. RES. Published online January 3, 2022:1-12. doi:10.1159/000520884